Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition
Authors:
- 27 February 2009
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 16 (9) , 693-702
Abstract
Oncogenic ras genes relate to the development of human cancers. In this study, we used a plasmid-mediated short-hairpin RNA (shRNA) targeting N-ras gene to combine with clinical drug vincristine (VCR) for the treatment of human hepatoma cells. Our results showed that anti-N-Ras shRNA expression vector (pCSH1-shNR) knocked down the target mRNA and protein. Higher efficacy on growth inhibition was observed when pCSH1-shNR was combined with VCR. This synergistic effect was associated with abrogation of VCR-induced overexpressions of P-glycoprotein and multidrug resistance-associated protein 1 by pCSH1-shNR through downregulations of N-Ras and total Ras. Western blot analysis showed that pCSH1-shNR-induced downregulations of N-Ras and total Ras were potentiated by VCR. Following Ras downregulation, phosphorylations of ERK1/2 and Akt were dramatically inhibited by combinatory treatment. The data showed that pCSH1-shNR-induced inhibition of nuclear factor-κB was enhanced by VCR. In addition, the combination of pCSH1-shNR and VCR synergistically inhibited the growth of human hepatoma HepG2 in vivo. Our findings suggested that combination of gene-specific therapeutics and appropriate chemotherapeutic agents might be a promising approach for the treatment of human hepatocellular carcinoma.Keywords
This publication has 39 references indexed in Scilit:
- In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway– and microtubule-targeting inhibitorsMolecular Cancer Therapeutics, 2007
- EGF Induces Cell Motility and Multi-Drug Resistance Gene Expression in Breast Cancer CellsCell Cycle, 2006
- Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cellsInternational Journal of Cancer, 2005
- Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancerCancer Gene Therapy, 2004
- Mdr1 Gene Expression and Mutations in Ras Proto-oncogenes in Acute Myeloid LeukemiaLeukemia & Lymphoma, 2002
- Inhibition of MAPK Activity, Cell Proliferation, and Anchorage-Independent Growth by N-Ras Antisense in an N- ras -Transformed Human Cell LineAntisense and Nucleic Acid Drug Development, 2001
- Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cellsOncogene, 1999
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991
- ras GENESAnnual Review of Biochemistry, 1987
- Ras GenesAnnual Review of Biochemistry, 1987